HPE Europe is back!
Join the biggest names in healthcare, life sciences and private equity for an unforgettable day of thought-provoking discussions, cutting-edge insights and valuable networking opportunities at the...more
8/16/2023
/ Artificial Intelligence ,
Digital Health ,
Events ,
Health Care Providers ,
Health Information Technologies ,
Health Technology ,
Healthcare Facilities ,
Investment Banks ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
Key Trends & Opportunities in Life Sciences and Healthcare Investing -
The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more
12/9/2022
/ Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions.
We will be joined by investors including key players...more
6/9/2021
/ Acquisitions ,
Business Valuations ,
Coronavirus/COVID-19 ,
Financing ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Lenders ,
Leveraged Loans ,
Life Sciences ,
Mergers ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Management ,
Webinars
McDermott was delighted to partner with the BVCA (British Venture Capital Association) on its recent virtual Sector Forum Series: Healthcare event. The event gathered industry experts – from entrepreneurs, to investors and...more
12/3/2020
/ Capital Markets ,
Digital Health ,
Entrepreneurs ,
EU ,
Healthcare ,
Investment ,
Investment Adviser ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
UK ,
Venture Capital
Our Focus on Private Equity provides a global perspective on some of the challenges being faced by PE firms and how these can be successfully addressed. It also examines some of the many opportunities available, e.g., by...more
9/9/2015
/ Abuse of Dominance ,
China ,
Corruption ,
Data Privacy ,
Data Protection ,
Delisting ,
Dodd-Frank ,
Due Diligence ,
Employee Privacy Rights ,
European Court of Justice (ECJ) ,
Exit Tax ,
Expatriates ,
France ,
FRAND ,
Gender Equity ,
Germany ,
Injunctions ,
Investors ,
Management Fees ,
New Legislation ,
Oil & Gas ,
Oil Prices ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Private Equity ,
Private Equity Funds ,
Quotas ,
Risk Management ,
Securities and Exchange Commission (SEC) ,
Standard Essential Patents ,
Transparency ,
UK ,
White Collar Crimes